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Abstract  We  present  a  case  of  allergic  reaction  to  patent  blue  in  a  patient  who  underwent
excision of  sentinel  lymph  node  associated  with  segmental  breast  resection.  About  20  min
after the  dye  injection,  the  patient  developed  hypotension  (BP  =  70  ×  30  mmHg)  associated  with
increased  heart  frequency.  The  patient  was  treated  successfully  with  decreased  inspired  frac-
tion of  inhaled  anesthetic  and  ﬂuid  replacement.  At  the  end  of  the  procedure,  she  presented
with bluish  urticarial-like  plaques  on  the  head,  neck,  upper  limbs,  and  trunk;  hydrocortisone
was then  used.  The  patient  recovered  uneventfully  and  was  discharged  from  the  PACU  2  h  after
the end  of  surgery  without  skin  changes,  and  was  discharged  from  hospital  on  the  morning  after
surgery.  The  incidence  of  allergic  reactions  with  the  use  of  patent  blue  is  far  superior  to  the
hypersensitivity  reactions  seen  with  anesthetic  and  adjuvant  drugs.  Therefore,  the  anesthesi-
ologist must  be  aware  of  cardiovascular  instability  associated  with  skin  changes  during  the  use
of patent  blue,  for  early  diagnosis  and  appropriate  treatment  of  this  hypersensitivity  reaction
to this  dye.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).PALAVRAS-CHAVE Reac¸ão alérgica  ao  corante  azul  patente  em  cirurgia  de  mama  --  relato  de  caso
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Resumo  Os  autores  apresentam  um  caso  de  reac¸ão  alérgica  ao  azul  patente  em  uma  paciente
submetida  à  exérese  de  linfonodo  em  sentinela  associada  a  uma  ressecc¸ão  segmentar  de
mama. Paciente  apresentou  aproximadamente  pós  20  minutos  da  injec¸ão  do  corante  hipotensão
(PA =  70  ×  30  mmHg)  associada  a  aumento  da  frequência  cardíaca.  Foi  tratada  satisfatoriamente Study performed at the Department of Anesthesiology, Hospital Universitário Oswaldo Cruz, Universidade de Pernambuco, Recife, PE,
Brazil.
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com  diminuic¸ão  da  frac¸ão  inspirada  do  anestésico  inalatório  e  reposic¸ão  volêmica.  No  ﬁm  do
procedimento  apresentava  placas  urticariformes  azuladas  em  cabec¸a,  pescoc¸o,  membros  super-
iores e  tronco  e  foi  usada  hidrocortisona.  Evoluiu,  sem  intercorrências,  na  sala  de  recuperac¸ão
pós-anestésica  e  teve  alta  duas  horas  após  o  término  do  procedimento  cirúrgico  sem  a  presenc¸a
das alterac¸ões  cutâneas.  Alta  hospitalar  na  manhã  seguinte  à  cirurgia.  A  incidência  de  reac¸ões
alérgicas  com  o  emprego  do  azul  patente  é  muito  superior  às  reac¸ões  de  hipersensibilidade
observadas  com  drogas  anestésicas  e  adjuvantes.  Portanto,  o  anestesiologista  deve  ﬁcar  atento
à instabilidade  cardiovascular  associada  a  alterac¸ões  cutâneas  quando  do  uso  do  azul  patente
para o  diagnóstico  precoce  e  tratamento  adequado  dessa  reac¸ão  de  hipersensibilidade  com  o
emprego do  corante.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este
é um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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entinel  lymph  node  biopsy  for  early  breast  cancer  surgical
reatment  has  been  widely  used  as  part  of  routine  protocol
nd,  in  most  cases,  it  prevents  total  lymphadenectomy.1,2
atent  blue  dye  or  the  radioisotope  technetium  may  be
sed  alone  or  in  combination  to  identify  the  lymph  node.1
owever,  there  are  reports  of  hypersensitivity  reactions
ediated  by  IgE  to  blue  dye,  with  an  average  incidence
f  1.8%  (0.1%  to  2.8%);  in  some  cases  these  reactions  can
e  severe  and  yield  serious  hemodynamic  effects  requiring
asoactive  drugs.1--4 This  frequency  is  higher  than  the  hyper-
ensitivity  reactions  seen  during  anesthesia,  which  is  around
.01%  to  0.02%.5
Another  effect  seen  with  the  use  of  patent  blue  are  pulse
ximetry  changes  because  it  interferes  with  the  wavelength
eading  used  to  measure  the  oxyhemoglobin.2 The  objective
f  this  paper  is  to  present  a  case  of  intraoperative  aller-
ic  reaction  after  subdermal  periareolar  injection  of  patent
lue  dye.
ase report
emale  patient,  45  years  old,  72  kg,  ASA  P2,  referred  from
he  Oncology  Center  (CEON)  of  the  Oswaldo  Cruz  Uni-
ersity  Hospital,  University  of  Pernambuco  (UPE),  Recife,
cheduled  for  segmental  resection  of  the  left  breast  with
entinel  lymph  node  resection.  During  preanesthetic  eval-
ation,  the  patient  reported  history  of  hypertension  and
se  of  enalapril,  without  other  comorbidities;  she  denied
moking  and  allergies  to  medicines,  foods,  and  latex,  and
eported  being  a  social  drinker,  using  tranquilizers  (bro-
azepam),  and  having  undergone  previous  anesthesia  with-
ut  complications.  Preoperative  tests,  such  as  cardiac  exam-
nation,  blood  count,  coagulation,  biochemistry  (urea,  glu-
ose,  creatinine,  AST,  ALT),  and  urinalysis  were  normal.  The
atient  was  not  premedicated.  At  the  operating  room,  ven-
clysis  was  performed  at  the  left  upper  limb  with  20G  Teﬂon
atheter.  Basic  monitoring  with  cardioscope,  pulse  oximeter,
nd  noninvasive  blood  pressure  showed  normal  sinus  rhythm,
eart  rate  (HR)  of  90  bpm,  oxygen  saturation  (SpO2) of  98%,
nd  blood  pressure  of  130  ×  70  mmHg.  After  preoxygenation
ith  100%  O2 via  face  mask  and  administration  of  cefazolin
D
T
t2  g),  induction  of  anesthesia  was  achieved  with  fentanyl
250  g),  propofol  (150  mg)  and  rocuronium  (50  mg).  Tra-
heal  intubation  was  performed  with  a  7.5  mm  cuffed
ube  and  basic  monitoring  complemented  with  capnogra-
hy;  controlled  mechanical  ventilation  with  570  mL  tidal
olume  and  12  ipm  respiratory  rate.  At  that  point,  car-
iorespiratory  parameters  evidenced  normal  sinus  rhythm,
R  85  bpm,  SpO2 100%,  ETCO2 30,  and  PA  110  ×  65  mmHg.
aintenance  of  anesthesia  was  achieved  with  sevoﬂurane
2--2.5%)  and  O2/N2O  (50/50%).  Immediately  before  the  inci-
ion,  a  subdermal  periareolar  injection  of  2.5%  patent  blue
2  mL)  was  performed.  About  20  min  after  the  blue  dye
njection,  hypotension  (70  ×  30  mmHg)  and  increased  HR
100  bpm)  occurred  without  changes  in  heart  rhythm,  SpO2,
nd  capnography.  Ringer’s  lactate  (400  mL)  was  adminis-
ered  and  end-tidal  sevoﬂurane  concentration  decreased
o  1.5%.  About  10  min  after  volume  replacement  and  a
ecrease  in  the  fraction  of  inspired  halogenated,  blood  pres-
ure  was  100  ×  60  mmHg  and  HR  90  bpm,  without  changes  in
he  remaining  parameters.  The  anesthetic-surgical  proce-
ure  went  through  without  complications.  Dipyrone  (2  g)  was
sed  for  postoperative  analgesia.  The  duration  of  surgery
as  50  min.  At  the  end  of  the  procedure,  atropine  (1  mg)
nd  neostigmine  (2  mg)  were  used  for  neuromuscular  block-
de  reversal.  After  surgical  ﬁeld  removal,  the  presence  of
umerous  urticaria-like  plates  (bluish)  was  observed  mainly
n  the  face,  neck,  upper  limbs,  and  thorax  (Figs.  1  and  2).
ydrocortisone  (500  mg)  was  administered.  The  patient
uickly  awakened  from  anesthesia  and  was  extubated  in
he  operating  room.  She  was  conscious,  complained  of
ild  pruritus,  free  of  pain,  and  with  cardiovascular  and
espiratory  stability  (blood  pressure:  150  ×  90  mmHg,  HR:
5  bpm,  and  SpO2:  98%).  The  patient  presented  with  nau-
ea,  received  ondansetron  (8  mg),  and  was  taken  to  the
ost-anesthesia  care  unit  (PACU).  After  60  min,  the  patient
ad  no  skin  changes  and  was  discharged  from  PACU  120  min
fter  surgery.  The  patient  was  discharged  from  hospital  the
orning  after  surgery  without  complications.iscussion
he  most  commonly  used  dyes  for  sentinel  lymph  node  iden-
iﬁcation  are  isossulfan  blue  (commonly  used  in  Europe)
Allergic  reaction  to  patent  blue  in  breast  surgery  
Figure  1  Presence  of  numerous  urticaria-like  plaques  on  the
face, neck,  upper  limbs  and  chest.
Figure  2  Presence  of  numerous  urticaria-like  plaques.
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nd  patent  blue  (commonly  used  in  Brazil  and  the  United
tates)  and  less  frequently  methylene  blue.1,6 Both  the
sossulfan  blue  and  patent  blue  belong  to  the  group  of  tri-
rylmethane  dyes.  Patent  blue  has  an  additional  hydroxyl
roup.1 Numerous  immediate  hypersensitivity  reactions
ave  been  attributed  to  dyes  and  there  may  be  a  cross-
ensitivity  between  the  two  drugs.1,6 In  contrast,  methylene
lue  has  been  considered  safer  than  patent  blue  and  is  an
ffective  option  to  it  to  identify  the  sentinel  lymph  node,
 fact,  however,  contested  by  some  authors.1 There  is  evi-
ence  that  about  2.7%  of  the  population  would  be  allergic
o  blue  dye,  which  may  be  due  to  sensitization  caused  by
epeated  exposure  to  some  products,  such  as  textiles,  cos-
etics,  paper,  leather,  and  drugs  containing  these  dyes.1
fter  the  intradermal  or  intraparenchymal  injection,  patent
lue  is  taken  up  by  the  lymphatic  vessels  from  draining  area,
inds  to  albumin,  and  two  thirds  are  absorbed  in  the  ﬁrst
our  while  the  totality  in  24  h.  It  is  excreted  in  the  urine  and
ile,  and  the  patient  urine  may  turn  blue  for  up  to  24  h.1,3
There  are  three  degrees  of  severity  associated  with
he  hypersensitivity  reactions  to  patent  blue:3,4 grade  I
69--87%),  characterized  by  bluish  color  urticaria,  pruri-
us,  and  general  rasch;  grade  II  (3.2--8%),  characterized
y  hypotension  (systolic  blood  pressure  <70  mmHg)  with-
ut  the  need  for  vasopressor,  and  absence  of  bronchospasm
nd  laryngospasm;  grade  III  (1.1%),  characterized  by  severe
ardiovascular  collapse  that  require  vasopressor,  suspen-
ion  of  the  surgical  procedure,  and  patient’s  transfer  to
he  intensive  care  unit.  The  early  signs  of  allergic  reac-
ion  are  hypotension  and  skin  rash  without  bronchospasm
r  airway  edema.  Although  an  initial  manifestation,  the  skin
hanges  are  not  always  immediately  seen  because  of  the
rapes.5 The  late  onset  of  hypersensitivity  occurs  between
0  and  45  min  after  the  dye  injection  (mean  =  17  min),  unlike
he  usual  hypersensitivity  reactions  seen  during  anesthesia
hat  occurs  earlier,  which  often  slows  down  the  differen-
ial  diagnosis  of  allergic  reaction.3,5 Skin  reactions  disappear
rom  1  to  20  h.3 Treatment  varies  according  to  the  sever-
ty  of  the  allergic  symptoms.  In  patients  with  grade  I or
I,  drug  treatment  is  based  on  corticosteroids  (hydrocor-
isone,  dexamethasone),  antihistamines  (diphenhydramine,
romethazine),  and  volume  replacement  with  crystalloid.
n  patients  classiﬁed  as  grade  III,  there  is  a  need  for  vaso-
ressor  (epinephrine,  metaraminol,  etilefrine,  ephedrine,
oradrenaline).  Vasopressor  response  may  be  obtained  with
 starting  dose  of  the  drug  or  may  require  prolonged  drug
nfusion.1--4 Cardiovascular  system  depression  may  be  pro-
onged  and  require  cardiovascular  support  and  admission  to
he  intensive  care  unit.  Cardiac  arrest  is  infrequent,  with
atisfactory  resuscitation.6 We  found  no  case  of  death  in
he  literature  due  to  allergic  reaction  to  patent  blue.  Note-
orthy  to  anesthesiologists  is  that  the  allergic  reactions  to
atent  blue  may  be  biphasic  with  the  occurrence  of  a  sub-
equent  episode  of  hypotension  between  six  and  8  h  after
he  initial  event.  Patients  should  be  monitored  in  the  PACU
r  ICU  during  this  period,  even  if  hemodynamically  stable.5
ositive  skin  test  for  allergies  to  patent  blue  and  increased
erum  histamine  levels  (normal  value  ≤10  nmoL  L−1),  IgE,
nd  tryptase  (due  to  mast  cell  degranulation;  normal
alue  =  13.5  g  L−1) are  usually  present  in  these  patients.5--8
ecause  of  histamine  short  elimination  half-life  (15--20  min),
ollecting  blood  30  min  after  the  hypersensitivity  reaction
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s  recommended.  Serum  tryptase  has  a  peak  plasma  level
ithin  an  hour  and  remains  high  for  6  h.5 Two  samples  of
ryptase  with  60  and  120  min  are  recommended.  Normal
ryptase  levels  do  not  exclude  a  hypersensitivity  reaction,
s  some  allergic  reactions  are  mediated  by  basophils  and
omplement  activation,  which  does  not  increase  the  serum
evels  of  tryptase.6 The  hypersensitivity  test  by  injecting
 small  amount  of  the  drug  and  waiting  a  few  minutes  to
heck  for  these  allergic  reactions  has  been  recommended.
owever,  the  use  of  test  dose  is  controversial  and  there  is  no
vidence  of  reduced  anaphylaxis.9 The  skin  test  (skin  prick
r,  mainly,  intradermal)  in  which  a  much  smaller  volume  than
he  test  dose  is  used  seems  to  be  the  ideal  test  with  high
ensitivity  and  speciﬁcity  to  identify  patients  with  hyper-
ensitivity  to  patent  blue.9 Allergic  patients  and  those  using
ngiotensin  converting  enzyme  inhibitors  or  angiotensin  II
eceptor  inhibitor  are  at  risk  to  develop  allergic  reactions
ith  the  use  of  patent  blue.5
Another  effect  seen  with  the  use  of  patent  blue  is
nterference  in  pulse  oximeter  readings,  which  causes  an
pparent  decrease  in  oxygen  saturation.  This  interference  is
ue  to  the  absorption  peak  of  the  patent  blue  light  (638  mm)
e  very  close  to  that  of  deoxyhemoglobin  (660  mm).5 The
ncreased  light  absorption  in  this  region  may  be  interpreted
y  the  pulse  oximeter  as  the  presence  of  deoxyhemoglobin
nd  falsely  decrease  oxygen  saturation.5 Latency  and  dura-
ion  of  oxygen  saturation  fall  depend  on  the  site  of  injection
f  patent  blue.  Intravascular  injection  causes  an  imme-
iate  and  severe  drop  in  oxygen  saturation  that  persists
or  a  few  minutes.5 When  administered  into  the  mammary
arenchyma,  a  reduction  of  11%  (5%  on  average)  occurs
5--30  min  after  injection.5
Hypersensitivity  reactions  to  patent  blue  are  much  more
requent  than  those  usually  seen  during  anesthesia  and
ay  range  from  skin  changes  to  severe  and  prolonged
ardiovascular  depression  and  require  admission  to  the
ntensive  care  unit  and  cardiovascular  support.  Our  patient
9M.V.M.  Maranhão  et  al.
ad  a  hypersensitivity  reaction  grade  II  due  to  subcutaneous
njection  of  patent  blue,  which  evolved  satisfactorily  with-
ut  sequelae.  Therefore,  anesthesiologists  should  be  aware
f  allergy  to  patent  blue  in  case  of  cardiovascular  instabil-
ty  and  look  for  the  presence  of  skin  changes  that  conﬁrm
he  clinical  diagnosis  of  hypersensitivity  reaction,  which  may
e  supplemented  by  measurement  of  serum  tryptase,  his-
amine  and  IgE,  as  well  as  skin  tests.
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